Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Single-centre, open-label, randomised, three-part, two-way crossover study in 84 healthy
volunteers. In each part, the study consisted of two consecutive single-dose treatment
periods separated by a washout period of at least 14 days.